2013 annual financial data
Alaunos Therapeutics 2013 Operating cash flow margin
Direct answer
Operating cash flow margin was -7,438.63%.
Operating income was -57,713,000 USD and net income was -57,107,000 USD.
Operating cash flow was -59,509,000 USD.
Get free Alaunos Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 800,000 USD
- Operating income
- -57,713,000 USD
- Net income
- -57,107,000 USD
- Operating cash flow
- -59,509,000 USD